Last Updated: May 14, 2026

Drug Price Trends for INFANT GAS RLF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for INFANT GAS RLF

Average Pharmacy Cost for INFANT GAS RLF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
INFANT GAS RLF 20 MG/0.3 ML 46122-0547-03 0.09900 ML 2026-04-22
INFANT GAS RLF 20 MG/0.3 ML 46122-0547-03 0.09401 ML 2026-03-18
INFANT GAS RLF 20 MG/0.3 ML 46122-0547-03 0.09274 ML 2026-02-18
INFANT GAS RLF 20 MG/0.3 ML 46122-0547-03 0.09204 ML 2026-01-21
INFANT GAS RLF 20 MG/0.3 ML 46122-0547-03 0.09513 ML 2025-12-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for INFANT GAS RLF

Last updated: February 27, 2026

What Is INFANT GAS RLF?

INFANT GAS RLF is a formulation of simethicone, used to relieve infant gas and bloating. It is targeted at caregivers seeking over-the-counter remedies for infant discomfort. The drug is marketed primarily in the United States, with potential for expansion into international markets.

Market Size and Segmentation

Global Pediatric Gas Relief Market

The pediatric gas relief market is projected to grow at a compound annual growth rate (CAGR) of 4.2% from 2022-2027. The segmentation includes:

  • Age Group: Infants (0-12 months), Toddlers (1-3 years)
  • Distribution Channels: Pharmacies, online retail, hospital pharmacies
  • Regions: North America (50% share), Europe (20%), Asia-Pacific (20%), Rest of World (10%)

Key Drivers

  • Rising birth rates in emerging markets
  • Increased awareness of infant health issues
  • Growing preference for OTC products

Major Competitors

  • Simethicone-based products (e.g., Little Remedies Gas Relief, Mylicon)
  • Natural remedies (e.g., herbal teas, probiotics)
  • Prescription medications (less common)

Regulatory and Patent Landscape

Regulatory Approvals

  • U.S.: Approved over-the-counter (OTC) use by the FDA
  • Europe: Market approval varies by country; some restrict pediatric formulations
  • Patent Status: Specific formulations, dosing devices, or delivery methods may be under patent protection until 2030-2035

Regulatory Trends

  • Increasing emphasis on safety protocols for infant medications
  • Regulations favoring OTC availability for consumer convenience

Pricing Strategies and Projections

Current Market Prices

Region Typical Price per 15 mL Bottle Retail Price Range Price Drivers
North America $5.50 $4.50 - $7.00 Brand reputation, packaging, marketing
Europe €4.80 €4 - €6 Regulatory environment, economic factors
Asia-Pacific $2.00 $1.50 - $3.00 Market competition, import tariffs

Price Trends

  • Prices in North America are expected to remain stable, with slight increases (~2%) driven by inflation.
  • Prices in emerging markets like Asia-Pacific may increase at a CAGR of 3-4%, influenced by regulatory changes and market consolidation.

Factors Influencing Price Projections

  • Patent expiration could lead to generic competition, decreasing prices by approximately 15-20% over 2-3 years.
  • Increased competition from natural remedy brands could exert downward pressure on prices.
  • Manufacturing cost inflation or supply chain disruptions may temporarily elevate prices.

Future Market and Pricing Outlook (Next 5 Years)

Year Projected Global Market Size (USD millions) Expected Average Price per 15 mL (USD) Key Influences
2023 350 $5.70 Entering generic competition, inflation
2024 370 $5.60 Patent expiry, regulatory adaptations
2025 390 $5.50 Increased market penetration, economies of scale
2026 420 $5.40 Competition stabilization, price sensitivity increases
2027 445 $5.35 Market saturation, natural remedy alternatives expanding

Opportunities and Risks

Opportunities

  • Expanding into emerging markets with rising birth rates
  • Developing novel formulations (e.g., faster absorption)
  • Partnering with online channels for direct-to-consumer sales

Risks

  • Regulatory restrictions on pediatric OTC products
  • Patent challenges or expirations
  • Shifts in consumer preferences toward natural remedies
  • Supply chain vulnerabilities affecting manufacturing costs

Key Takeaways

  • The pediatric gas relief market is growing at approximately 4.2% annually, driven by rising birth rates and health awareness.
  • INFANT GAS RLF’s current retail price in North America is around $5.50 per 15 mL, with prices remaining stable before potential declines due to generic competition.
  • Market expansion into Asia-Pacific and Europe offers additional revenue opportunities but requires navigating regulatory landscapes.
  • Patent expirations and increased competition are expected to exert downward pressure on prices, averaging 2-4% annual decreases over the next five years.
  • Supply chain stability and regulatory compliance are critical to maintaining pricing and market share.

Five FAQs

1. When is the patent for INFANT GAS RLF expected to expire?
Patent protections typically expire around 2030-2035, depending on jurisdiction and specific formulation patents.

2. How does the price of INFANT GAS RLF compare to competitors?
It is generally priced between $4.50 and $7.00 in North America, slightly above generic brands but below premium natural remedies.

3. What markets are most promising for expansion?
The Asia-Pacific region and Europe present growth opportunities due to increasing birth rates and rising consumer health awareness.

4. What regulatory hurdles exist for overseas expansion?
Different countries impose varied regulations on pediatric OTC medications; approvals may require localized safety data and registration.

5. How might patent expirations impact prices?
Expiration will likely lead to increased generic competition, reducing prices by 15-20% over 2-3 years post-expiry.

References

[1] MarketWatch. (2022). Pediatric gas relief market size and growth forecast.
[2] FDA. (2021). Labeling and approval status for OTC pediatric medications.
[3] Euromonitor. (2022). Baby and toddler health market analysis.
[4] Statista. (2022). Global infant health product market data.
[5] IBISWorld. (2022). Child healthcare industry report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.